AR091679A1 - Modulares alostericos positivos del receptor de acetilcolina nicotinico - Google Patents

Modulares alostericos positivos del receptor de acetilcolina nicotinico

Info

Publication number
AR091679A1
AR091679A1 ARP130102397A AR091679A1 AR 091679 A1 AR091679 A1 AR 091679A1 AR P130102397 A ARP130102397 A AR P130102397A AR 091679 A1 AR091679 A1 AR 091679A1
Authority
AR
Argentina
Prior art keywords
acetilcoline
nicotinic
receiver
positive allosteric
modular
Prior art date
Application number
Other languages
English (en)
Spanish (es)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2012/063219 external-priority patent/WO2013007621A1/fr
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of AR091679A1 publication Critical patent/AR091679A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP130102397 2012-07-06 2013-07-05 Modulares alostericos positivos del receptor de acetilcolina nicotinico AR091679A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2012/063219 WO2013007621A1 (fr) 2011-07-08 2012-07-06 Modulateurs allostériques positifs des récepteurs nicotiniques d'acétylcholine

Publications (1)

Publication Number Publication Date
AR091679A1 true AR091679A1 (es) 2015-02-18

Family

ID=48745970

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP130102397 AR091679A1 (es) 2012-07-06 2013-07-05 Modulares alostericos positivos del receptor de acetilcolina nicotinico
ARP130102396 AR091678A1 (es) 2012-07-06 2013-07-05 Modulares alostericos positivos del receptor de acetilcolina nicotinico

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP130102396 AR091678A1 (es) 2012-07-06 2013-07-05 Modulares alostericos positivos del receptor de acetilcolina nicotinico

Country Status (2)

Country Link
AR (2) AR091679A1 (fr)
WO (2) WO2014006120A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20207149B (en) 2016-03-22 2020-09-10 Merck Sharp & Dohme Allosteric modulators of nicotinic acetylcholine receptors
TWI839355B (zh) 2018-05-01 2024-04-21 美商默沙東有限責任公司 菸鹼乙醯膽鹼受體之螺哌啶異位調節劑

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010003155A (es) 2007-10-04 2010-04-01 Hoffmann La Roche Derivados de ciclopropil aril amida y uso de los mismos.
CN105130957A (zh) 2009-05-29 2015-12-09 拉夸里亚创药株式会社 作为钙或钠通道阻滞剂的芳基取代羧酰胺衍生物
US8497271B2 (en) * 2009-10-07 2013-07-30 Bristol-Myers Squibb Company Modulators of G protein-coupled receptor 88
UA111746C2 (uk) 2011-07-08 2016-06-10 Х. Луннбек А/С Позитивні алостеричні модулятори нікотинового рецептора ацетилхоліну

Also Published As

Publication number Publication date
WO2014006117A1 (fr) 2014-01-09
WO2014006120A1 (fr) 2014-01-09
AR091678A1 (es) 2015-02-18

Similar Documents

Publication Publication Date Title
AR102177A1 (es) Compuestos de heteroarilo como inhibidores de btk y usos de los mismos
CR20160291A (es) Análogos de cortistatina y síntesis y usos de los mismos
EA201591486A1 (ru) Соединения имидазопиридина
AR101815A1 (es) Compuestos y composiciones como inhibidores de quinasa
PE20151606A1 (es) DERIVADOS DE NAFTIRIDINA UTILES COMO ANTAGONISTAS DE LA AvB6 INTEGRINA
BR112017019286A2 (pt) composto de fórmula (i) ou um sal farmaceuticamente aceitável deste
AR100809A1 (es) Inhibidores de fosfatidilinositol 3-quinasa
AR088828A1 (es) DERIVADOS DE CICLOHEXILAMINA QUE TIENEN ACTIVIDAD COMO AGONISTAS ADRENERGICOS b2 Y COMO ANTAGONISTAS MUSCARINICOS M3
AR094299A1 (es) Derivados de ftalazin-1(2h)-ona sustituidos
AR092347A1 (es) Derivados de azaindol
AR097079A1 (es) SALES DE DERIVADOS DE 2-AMINO-1-HIDROXIETIL-8-HIDROXIQUINOLIN-2(1H)-ONA QUE TIENEN ACTIVIDAD ANTAGONISTA DE RECEPTORES MUSCARÍNICOS ASÍ COMO ACTIVIDAD AGONISTA DEL RECEPTOR b2 ADRENÉRGICO
CR20140294A (es) Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina
AR090587A1 (es) Compuestos triciclicos sustituidos con actividad hacia los receptores ep1
AR094812A1 (es) Derivado de piridina monocíclico como inhibidor del fgfr
CR20150419A (es) Derivados sustituidos del ácido bisfenil butanóico fosfónico como inhibidores de la nep
AR107321A1 (es) Compuestos antiproliferativos, y sus composiciones farmacéuticas y usos
AR090557A1 (es) DERIVADOS IMIDAZOLICOS AGONISTAS ADRENERGICOS a2
AR096153A1 (es) Derivados de pirrolo[2,3-d]pirimidina
AR100440A1 (es) Derivados de carboxamida como inhibidores selectivos de smurf1
AR101222A1 (es) Derivados de piridona
PE20190803A1 (es) 1-arilnaftiridin-3-carboxamidas 7-sustituidas y su uso
AR091679A1 (es) Modulares alostericos positivos del receptor de acetilcolina nicotinico
AR096424A1 (es) Compuestos de 3,4-dihidro-2h-isoquinolin-1-ona y 2,3-dihidro-isoindol-1-ona
AR113923A1 (es) Derivados de imidazopiridina y su uso como medicamento
AR100126A1 (es) Activadores de herg policíclicos

Legal Events

Date Code Title Description
FB Suspension of granting procedure